The impaired acute insulin response in newly diagnosed Type 2 diabetic patients can be restored by nateglinide and repaglinide

被引：0
|
作者：
Wang, FN [1 ]
Liao, ZH [1 ]
Yao, B [1 ]
Li, YB [1 ]
Hu, GL [1 ]
Weng, JP [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Peoples R China
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
701
引用
收藏
页码：A254 / A254
页数：1
相关论文
共 50 条
  • [1] Both Nateglinide and Acarbose Improve Postprandial Ghrelin Response in Patients With Newly Diagnosed Type 2 Diabetes
    Zheng, Fenping
    Yin, Xueyao
    Lu, Weina
    Zhou, Jiaqiang
    Li, Hong
    DIABETES, 2012, 61 : A703 - A704
  • [2] Glycemic Variability in Impaired Glucose Regulation and Newly Diagnosed Type 2 Diabetic Patients
    Wang, Chun
    Lv, Lifang
    Yang, Yanzhi
    He, Liping
    Liu, Guanjian
    Chen, Dawei
    Song, Yuanxia
    Chen, Lihong
    Li, Xiujun
    Tian, Haoming
    Zhang, Xiangxun
    Jian Zhou
    Jia, Weiping
    Ran, Xingwu
    DIABETES, 2010, 59 : A544 - A544
  • [3] Effects of Insulin Intensive Therapy on Insulin Resistance in Newly Diagnosed Type 2 Diabetic Patients
    Wan, Xuesi
    Ling Ma
    Juan Liu
    Huang, Zhimin
    Liu, Liehua
    Liu, Jianbin
    Yao, Bin
    Xiao, Haipeng
    Cao, Xiaopei
    Guan, Hongyu
    Liang, Sujuan
    Li, Yanbing
    DIABETES, 2010, 59 : A576 - A576
  • [4] Evaluation of the efficacy of repaglinide compared with glibenclamide in newly diagnosed type 2 diabetic patients by continuous glucose monitoring system
    Lu, JM
    Wang, XL
    Pan, CY
    Zhai, HW
    DIABETOLOGIA, 2005, 48 : A284 - A284
  • [5] Dose response of repaglinide in patients with newly diagnosed type 2 diabetes: Effect on B-cell secretion
    Dunseath, GJ
    Luzio, SD
    Cozma, L
    Owens, DR
    DIABETES, 2002, 51 : A96 - A96
  • [6] Comparison of effects of repaglinide and nateglinide on insulin secretion and postloading glucose excursions in patients with type 2 diabetes
    Rudovich, N
    Rochlitz, H
    Dieken, ML
    Pfeiffer, A
    DIABETES, 2003, 52 : A454 - A454
  • [7] Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus
    Wang, Liang-Chen
    Fang, Fu-Sheng
    Gong, Yan-Ping
    Yang, Guang
    Li, Chun-Lin
    MEDICINE, 2018, 97 (38)
  • [8] Newly diagnosed type 2 diabetic population in Belgium -: Response
    Pfützner, A
    Forst, T
    DIABETES CARE, 2002, 25 (03) : 638 - 639
  • [9] Dose response study of repaglinide, a non-sulphonylurea insulin secretagogue, in type 2 diabetic patients
    Owens, DR
    Luzio, S
    DIABETES, 1999, 48 : A350 - A350
  • [10] Effects of Insulin Intensive Therapy on β-Cell Function in Newly Diagnosed Type 2 Diabetic Patients
    Wan, Xuesi
    Deng, Wanping
    Chen, Ailing
    Guan, Hongyu
    Liu, Juan
    Huang, Zhimin
    Liang, Sujuan
    Liu, Liehua
    Liu, Jianbin
    Yao, Bin
    Xiao, Haipeng
    Cao, Xiaopei
    Li, Yanbing
    DIABETES, 2010, 59 : A559 - A559
12345